U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 47

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hereditary Cancer Screening - Colorectal & Gastric Cancer Panel (including Pancreatic Cancer) - (43 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
5843
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
5244
  • X Mutation scanning of select exons

Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
10999
  • X Mutation scanning of select exons

Common Hereditary Cancer Screening Panel

PreventionGenetics, part of Exact Sciences
United States
9455
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CentoCancer Comprehensive

Centogene AG - the Rare Disease Company
Germany
156107
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Solid Tumor Panel

Centogene AG - the Rare Disease Company
Germany
218135
  • C Sequence analysis of the entire coding region

CDKN1B - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Multi-Cancer + RNA Panel

Invitae
United States
14363
  • D Deletion/duplication analysis

Multiple endocrine neoplasia, type IV, 610755, Autosomal dominant; MEN4 (Multiple endocrine neoplasia type 4) (CDKN1B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Multiple endocrine neoplasia, type IV, 610755, Autosomal dominant; MEN4 (Multiple endocrine neoplasia type 4) (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

ENDOCRINE NEOPLASIA PANEL

IntelligeneCG LLC
United States
77
  • C Sequence analysis of the entire coding region

Invitae Genetic Health Screen

Invitae
United States
409164
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Cancer Screen

Invitae
United States
16062
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®)

Ambry Genetics
United States
14718
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for BrainTumorNext® (+RNAinsight®)

Ambry Genetics
United States
728
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®)

Ambry Genetics
United States
9571
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer®

Ambry Genetics
United States
14791
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CancerNext-Expanded®

Ambry Genetics
United States
12271
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext®

Ambry Genetics
United States
7229
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
122117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 47

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.